Rosati, G.; Camerlo, S.; Dalmazzo, M.; Padrini, M.; Busana, T.T.; De Gobbi, M.; Fornari, A.; Morotti, A.
Acute Promyelocytic Leukemia and Brugada Syndrome: A Report on the Safety of Arsenic Trioxide/All-Trans-Retinoic Acid Therapy. Hematol. Rep. 2023, 15, 440-447.
https://doi.org/10.3390/hematolrep15030045
AMA Style
Rosati G, Camerlo S, Dalmazzo M, Padrini M, Busana TT, De Gobbi M, Fornari A, Morotti A.
Acute Promyelocytic Leukemia and Brugada Syndrome: A Report on the Safety of Arsenic Trioxide/All-Trans-Retinoic Acid Therapy. Hematology Reports. 2023; 15(3):440-447.
https://doi.org/10.3390/hematolrep15030045
Chicago/Turabian Style
Rosati, Giorgio, Sofia Camerlo, Matteo Dalmazzo, Melissa Padrini, Tiziano Tommaso Busana, Marco De Gobbi, Alessandro Fornari, and Alessandro Morotti.
2023. "Acute Promyelocytic Leukemia and Brugada Syndrome: A Report on the Safety of Arsenic Trioxide/All-Trans-Retinoic Acid Therapy" Hematology Reports 15, no. 3: 440-447.
https://doi.org/10.3390/hematolrep15030045
APA Style
Rosati, G., Camerlo, S., Dalmazzo, M., Padrini, M., Busana, T. T., De Gobbi, M., Fornari, A., & Morotti, A.
(2023). Acute Promyelocytic Leukemia and Brugada Syndrome: A Report on the Safety of Arsenic Trioxide/All-Trans-Retinoic Acid Therapy. Hematology Reports, 15(3), 440-447.
https://doi.org/10.3390/hematolrep15030045